🔎 Trials Near Me

Home › Head and Neck Squamous Cell Carcinoma › Pennsylvania › Erie

Head and Neck Squamous Cell Carcinoma clinical trials in Erie, PA

6 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Erie (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

RecruitingPhase 3
  • UPMC Hillman Cancer Center Erie, Erie
  • Saint Vincent Hospital, Erie
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06992427

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

RecruitingPhase 3
  • UPMC Hillman Cancer Center Erie, Erie
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06589804

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

RecruitingPhase 2
  • UPMC Hillman Cancer Center Erie, Erie
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT02734537

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

RecruitingPhase 2/3
  • UPMC Hillman Cancer Center Erie, Erie
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT04333537

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

RecruitingPhase 2
  • UPMC Hillman Cancer Center Erie, Erie
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT06532279

Head and Neck Squamous Cell Carcinoma trials in other cities

Other studies in Erie

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.